Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

The announcement of Marvel Tokon: Fighting Souls from developer ArcSystem Works was met with near universal excitement when it was revealed last year at Sony's State of Play. Some of that excitement ...

In the development of diseases such as muscular dystrophy, cancer, Ebola and dengue, numerous chemical reactions take place ...

Up to $125 million in additional borrowing capacity provides further strategic flexibility -- $50 million of additional capacity funded at ...

Many organizations offer one or more leadership development training opportunities to their leaders—workshops, certificate programs, mentorship initiatives and retreats. The investment is real, so is ...

Which technologies, designs, standards, development approaches, and security practices are gaining momentum in multi-agent enterprise systems? We asked the experts. Agentic AI has emerged as the ...

Forbes contributors publish independent expert analyses and insights. Peter Bendor-Samuel is founder & executive chairman of Everest Group. This voice experience is generated by AI. Learn more. This ...

Researchers at the University of Basel have developed a gene therapy that could potentially treat a rare and currently fatal muscle disease in children. The study shows in animal models that a single ...

Roche has halted development of of Enspryng as a treatment to improve bone muscle health in Duchenne muscular dystrophy patients. (James Waldron) Roche’s autoimmune drug Enspryng is making solid ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...